Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity

W. Zhang, S. Telemaque, R. A. Augustyniak, P. Anderson, G. D. Thomas, J. An, Z. Wang, C. B. Newgard, R. G. Victor

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In our previous study, moderate increases in plasma leptin levels achieved via administration of recombinant adenovirus containing the rat leptin cDNA were shown to correct the abnormal metabolic profile in rats with diet-induced obesity, suggesting that these animals had developed resistance to the metabolic effects of leptin, which could be reversed by leptin gene over-expression. However, the effect of this therapeutic strategy on blood pressure was not investigated. The present study aimed to determine whether a moderate increase of endogenous plasma leptin levels affected arterial blood pressure in rats with diet-induced obesity and hypertension. The major finding from the present study was that the natural rise in plasma leptin with weight-gain is insufficient to counterbalance high blood pressure associated with obesity, additional increases of circulating leptin levels with adenoviral leptin gene therapy led to normalisation of blood pressure in high-fat diet-induced obese and hypertensive rats. Mechanistically, the reduction of blood pressure by leptin in obese rats was likely independent of α-adrenergic and acetylcholinergic receptor mediation. This is the first study to demonstrate that further increases in circulating leptin levels by leptin gene transfer during obesity could reduce blood pressure.

Original languageEnglish (US)
Pages (from-to)175-180
Number of pages6
JournalJournal of Neuroendocrinology
Volume22
Issue number3
DOIs
StatePublished - Mar 1 2010

Fingerprint

Leptin
Adenoviridae
Obesity
Diet
Hypertension
Blood Pressure
Metabolome
High Fat Diet
Therapeutic Uses
Genetic Therapy
Adrenergic Receptors
Weight Gain
Arterial Pressure
Complementary DNA
Gene Expression

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Cellular and Molecular Neuroscience

Cite this

Zhang, W. ; Telemaque, S. ; Augustyniak, R. A. ; Anderson, P. ; Thomas, G. D. ; An, J. ; Wang, Z. ; Newgard, C. B. ; Victor, R. G. / Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity. In: Journal of Neuroendocrinology. 2010 ; Vol. 22, No. 3. pp. 175-180.
@article{a3f6076a754a48f7ab5db27bc798d2d2,
title = "Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity",
abstract = "In our previous study, moderate increases in plasma leptin levels achieved via administration of recombinant adenovirus containing the rat leptin cDNA were shown to correct the abnormal metabolic profile in rats with diet-induced obesity, suggesting that these animals had developed resistance to the metabolic effects of leptin, which could be reversed by leptin gene over-expression. However, the effect of this therapeutic strategy on blood pressure was not investigated. The present study aimed to determine whether a moderate increase of endogenous plasma leptin levels affected arterial blood pressure in rats with diet-induced obesity and hypertension. The major finding from the present study was that the natural rise in plasma leptin with weight-gain is insufficient to counterbalance high blood pressure associated with obesity, additional increases of circulating leptin levels with adenoviral leptin gene therapy led to normalisation of blood pressure in high-fat diet-induced obese and hypertensive rats. Mechanistically, the reduction of blood pressure by leptin in obese rats was likely independent of α-adrenergic and acetylcholinergic receptor mediation. This is the first study to demonstrate that further increases in circulating leptin levels by leptin gene transfer during obesity could reduce blood pressure.",
author = "W. Zhang and S. Telemaque and Augustyniak, {R. A.} and P. Anderson and Thomas, {G. D.} and J. An and Z. Wang and Newgard, {C. B.} and Victor, {R. G.}",
year = "2010",
month = "3",
day = "1",
doi = "10.1111/j.1365-2826.2010.01953.x",
language = "English (US)",
volume = "22",
pages = "175--180",
journal = "Journal of Neuroendocrinology",
issn = "0953-8194",
publisher = "Wiley-Blackwell",
number = "3",

}

Zhang, W, Telemaque, S, Augustyniak, RA, Anderson, P, Thomas, GD, An, J, Wang, Z, Newgard, CB & Victor, RG 2010, 'Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity', Journal of Neuroendocrinology, vol. 22, no. 3, pp. 175-180. https://doi.org/10.1111/j.1365-2826.2010.01953.x

Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity. / Zhang, W.; Telemaque, S.; Augustyniak, R. A.; Anderson, P.; Thomas, G. D.; An, J.; Wang, Z.; Newgard, C. B.; Victor, R. G.

In: Journal of Neuroendocrinology, Vol. 22, No. 3, 01.03.2010, p. 175-180.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adenovirus-mediated leptin expression normalises hypertension associated with diet-induced obesity

AU - Zhang, W.

AU - Telemaque, S.

AU - Augustyniak, R. A.

AU - Anderson, P.

AU - Thomas, G. D.

AU - An, J.

AU - Wang, Z.

AU - Newgard, C. B.

AU - Victor, R. G.

PY - 2010/3/1

Y1 - 2010/3/1

N2 - In our previous study, moderate increases in plasma leptin levels achieved via administration of recombinant adenovirus containing the rat leptin cDNA were shown to correct the abnormal metabolic profile in rats with diet-induced obesity, suggesting that these animals had developed resistance to the metabolic effects of leptin, which could be reversed by leptin gene over-expression. However, the effect of this therapeutic strategy on blood pressure was not investigated. The present study aimed to determine whether a moderate increase of endogenous plasma leptin levels affected arterial blood pressure in rats with diet-induced obesity and hypertension. The major finding from the present study was that the natural rise in plasma leptin with weight-gain is insufficient to counterbalance high blood pressure associated with obesity, additional increases of circulating leptin levels with adenoviral leptin gene therapy led to normalisation of blood pressure in high-fat diet-induced obese and hypertensive rats. Mechanistically, the reduction of blood pressure by leptin in obese rats was likely independent of α-adrenergic and acetylcholinergic receptor mediation. This is the first study to demonstrate that further increases in circulating leptin levels by leptin gene transfer during obesity could reduce blood pressure.

AB - In our previous study, moderate increases in plasma leptin levels achieved via administration of recombinant adenovirus containing the rat leptin cDNA were shown to correct the abnormal metabolic profile in rats with diet-induced obesity, suggesting that these animals had developed resistance to the metabolic effects of leptin, which could be reversed by leptin gene over-expression. However, the effect of this therapeutic strategy on blood pressure was not investigated. The present study aimed to determine whether a moderate increase of endogenous plasma leptin levels affected arterial blood pressure in rats with diet-induced obesity and hypertension. The major finding from the present study was that the natural rise in plasma leptin with weight-gain is insufficient to counterbalance high blood pressure associated with obesity, additional increases of circulating leptin levels with adenoviral leptin gene therapy led to normalisation of blood pressure in high-fat diet-induced obese and hypertensive rats. Mechanistically, the reduction of blood pressure by leptin in obese rats was likely independent of α-adrenergic and acetylcholinergic receptor mediation. This is the first study to demonstrate that further increases in circulating leptin levels by leptin gene transfer during obesity could reduce blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=77949287559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949287559&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2826.2010.01953.x

DO - 10.1111/j.1365-2826.2010.01953.x

M3 - Article

C2 - 20059648

AN - SCOPUS:77949287559

VL - 22

SP - 175

EP - 180

JO - Journal of Neuroendocrinology

JF - Journal of Neuroendocrinology

SN - 0953-8194

IS - 3

ER -